Fig. 2

Predicted survival curves for drug-free (infliximab and/or immunosuppressant) in newly diagnosed CD patients with an elevated platelet-to-lymphocyte ratio
Predicted survival curves for drug-free (infliximab and/or immunosuppressant) in newly diagnosed CD patients with an elevated platelet-to-lymphocyte ratio